Evidence map›Paper›PMID 25522185›Full record

ArticleMolecular nutrition & food research2015

Dietary lipids modulate the expression of miR-107, an miRNA that regulates the circadian system.

Lidia Daimiel-Ruiz, Mercedes Klett-Mingo, Valentini Konstantinidou, Victor Micó, Juan F Aranda, Belén García, Javier Martínez-Botas, Alberto Dávalos, Carlos Fernández-Hernando, Jose M Ordovás

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Molecular nutrition & food research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 56 citations in OpenAlex.

  1. Chrono-Nutrition: Circadian Rhythm and Personalized Nutrition.International journal of molecular sciences · 2023
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Association of childhood traumatization and neuropsychiatric outcomes with altered plasma micro RNA-levels.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Lidia Daimiel-RuizNutritional Genomics of Cardiovascular Disease and Obesity, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain.
Mercedes Klett-Mingo
Valentini Konstantinidou
Victor Micó
Juan F Aranda
Belén García
Javier Martínez-Botas
Alberto Dávalos
Carlos Fernández-Hernando
Jose M Ordovás
Madrid Institute for Advanced Studies · ESIMDEA Food · ESYale University · USInstituto Ramón y Cajal de Investigación Sanitaria · ESUniversidad Autónoma de Madrid · ESUniversidad Complutense de Madrid · ES

Funding

Role of microRNAs in lipid metabolism and cardiovascular diseaseR01HL107953 · NHLBI · YALE UNIVERSITY · PI FERNANDEZ HERNANDO, CARLOS · 2011 to 2016
$2.4M
NHLBI NIH HHS R01 HL107953
6 · The paper itself

Abstract

scopeThe increased prevalence of cardiovascular diseases (CVDs) has been hypothesized to be the result of an increased exposure to a host of atherogenic environmental factors, paramount among them being unhealthy dietary habits. Long-chain n-3 polyunsaturated fatty acids have been shown to have cardio protective effects, partially due to their ability to regulate gene expression. In this regard, increasing attention has been devoted to the role of miRNAs as regulators of multiple metabolic pathways whose deregulation has been associated with CVD risk. METHODS AND

resultsIn this work, we investigated whether miRNA expression was regulated by docosahexanoic acid, conjugated linoleic acid, and cholesterol in Caco-2 cells. The modulated miRNAs, miR-107 was differentially expressed by all treatments and this modulation was independent of its hosting gene, PANK1, possibly through its own promoter, which contains binding sites for metabolically relevant transcription factors. Among the putative target genes of miR-107, we found some genes with key roles in circadian rhythm. Specifically, we demonstrated that binding of miR-107 to the CLOCK gene results in the deregulation of the circadian rhythm of the cells.

conclusionSince chronodisruption has been linked to metabolic disorders such as type 2 diabetes, atherosclerosis, obesity, and CVD, our findings suggests that miR-107 could represent a new approach for pharmacological treatment of these diseases.

Indexed as

AnimalsAtorvastatinCaco-2 CellsCholesterolCircadian ClocksCLOCK ProteinsDiet, High-FatDocosahexaenoic AcidsFenofibrateGene Expression RegulationHumansLinoleic Acids, ConjugatedMice, Inbred C57BLMicroRNAsPhosphotransferases (Alcohol Group Acceptor)Promoter Regions, GeneticAtorvastatinCholesterolCLOCK protein, humanCLOCK ProteinsDocosahexaenoic AcidsFenofibrateLinoleic Acids, ConjugatedMicroRNAsMIRN107 microRNA, humanpantothenate kinasePhosphotransferases (Alcohol Group Acceptor)Circadian rhythmDHADietary lipidsmiR-107

Identifiers

PMID25522185
PMCPMC4591752
OpenAlexW2042805768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.